Applied therapeutics to present at the ubs global healthcare conference

New york, may 19, 2022 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate in a fireside chat at the ubs global healthcare conference on wednesday, march 25, 2022 at 10:45 a.m. et in new york.
APLT Ratings Summary
APLT Quant Ranking